Sun Pharma commences Tender Offer for acquisition of InSite Vision
The tender offer is being made pursuant to an Offer to Purchase, dated September 29, 2015, and in connection with the previously announced Agreement and Plan of Merger, dated September 15, 2015, as amended and restated as of September 28, 2015, by and among InSite Vision, Ranbaxy, Inc. and Thea Acquisition Corporation.